Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-235-7 | CAS number: -
Carcinogenicity
Administrative data
Description of key information
No relevance of carcinogenic effect/potential
Key value for chemical safety assessment
Justification for classification or non-classification
No classification for carcinogenicity warranted under 67/548/EEC or Regulation 1272/2008.
Additional information
Methyl 12 -oxo-trans-10 -octadecenoate and methyl hydroxyoctadecadienoate were tested for carginogenic and tumor promoting activity on mouse skin (Arffmann and Glavind, 1971 and 1974). Methyl oleate, which was inactive in the preliminary screening was also tested. No safe evidence of any proper carcinogenic effect of the fatty acid esters was found; some degree of tumor promoting activity could be further investigated
By the same working group (Arffman and Glavind 1975) two fatty acid methyl esters, methyl oleate and methyl 12-oxo-trans-10-octadecenoate, have been tested for carcinogenicty by oral and subcutaneous administration in ST/a mice of both sexes. A positive effect of methyl oleate could not be assessed, while the results pointed to a promoter effect of methyl oxo-octadecenoate. Given in the diet, this compound increased the incidence and number of forestomach papillomas within 83 weeks after initiation by 4-nitroguinoline 1-oxide.
In a more comprehensive study (Swer et al., 1970) twenty-nine fatty acids and esters, lactones, and epoxy and peroxy compounds were tested for carcinogenic activity by repeated s.c. injections in mice. Sarcomas at the site of injection were elicited with 12-hydroxystearic acid , methyl 12-hydroxystearate, 4-ketostearic acid, stearohydroxamic acid , glycidyl laurate, glycidyl oleate, and p-nitroperoxybenzoic acid. Sarcomas were also elicited in mice given injections of lower doses of stearic acid and gamma-stearolactone. No carginogenic activity was recorded for methyl stearate.
After having assessed the whole category for all toxicological end points, and having verified no concern in any assessment, a consistent behaviour in respect of carcinogenicity can be previewed for Fatty acids C16 -C18 and C18 unsatd. methyl esters and
Fatty acids C16 -C18 and C18 unsatd.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
